{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:06:04Z","timestamp":1791345964375,"version":"4.3.1"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jsbmb.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T18:18:05Z","timestamp":1496773085000},"page":"38-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: Dysregulated glandular homeostasis, survival and metastasis"],"prefix":"10.1016","volume":"176","author":[{"given":"Edward J.","family":"Filardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2017.05.005_bib0005","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1470-2045(12)70425-4","article-title":"Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies","volume":"13","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/hmbci-2016-0005","article-title":"Hormones and endometrial carcinogenesis","volume":"25","author":"Kamal","year":"2016","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4137\/CMO.S32813","article-title":"Hormone receptors in serous ovarian carcinoma: prognosis, pathogenesis, and treatment considerations","volume":"10","author":"Voutsadakis","year":"2016","journal-title":"Clin. Med. Insights Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0020","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Million women study collaborators.. endometrial cancer and hormone-replacement therapy in the million women study","volume":"365","author":"Beral","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0025","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/aje\/kwn006","article-title":"Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women","volume":"167","author":"Moorman","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/2042098614568300","article-title":"Menopausal hormone therapy and breast cancer mortality: clinical implication","volume":"6","author":"Chlebowski","year":"2015","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0035","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 6","key":"10.1016\/j.jsbmb.2017.05.005_bib0040","first-page":"S15S1","article-title":"Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers","volume":"38","author":"Rebbeck","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0045","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaoncol.2015.0658","article-title":"Effect of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"1","author":"Metcalfe","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0050","doi-asserted-by":"crossref","first-page":"641","DOI":"10.6004\/jnccn.2016.0181","article-title":"NCCN guidelines update: Breast cancer","volume":"14","author":"Gradishar","year":"2016","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.12998\/wjcc.v1.i6.187","article-title":"Recurrent epithelial ovarian cancer and hormone therapy","volume":"1","author":"Yokoyama","year":"2013","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0060","first-page":"429","article-title":"Past, present, and future of hormonal therapy in recurrent endometrial cancer","volume":"6","author":"Carlson","year":"2014","journal-title":"Int. J. Womens Health"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jamcollsurg.2008.12.001","article-title":"Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease","volume":"208","author":"Gnerlich","year":"2009","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1056\/NEJM200101253440407","article-title":"Estrogen and the risk of breast cancer","volume":"344","author":"Clemons","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0075","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/pr.58.4.8","article-title":"International union of pharmacology: LXIV. estrogen receptors","volume":"58","author":"Dahlman-Wright","year":"2006","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0080","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/febs.12658","article-title":"Estrogen receptor \u03b1 mediates proliferation of breast cancer MCF-7 cells via a p21\/PCNA\/E2F1-dependent pathway","volume":"281","author":"Liao","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0085","first-page":"529","article-title":"Estrogens in the breast tissue: a systematic review","volume":"22","author":"Yaghjyan","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/modpathol.3880050","article-title":"Hormonal pathology of the endometrium","volume":"13","author":"Deligdisch","year":"2000","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0095","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fendo.2014.00192","article-title":"Estrogen biosynthesis and action in ovarian cancer","volume":"5","author":"Mungenast","year":"2014","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0100","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1290\/1071-2690(2000)036<0657:ESOOSE>2.0.CO;2","article-title":"Estrogen stimulation of ovarian surface epithelial cell proliferation","volume":"36","author":"Bai","year":"2000","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0105","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.69.4406","article-title":"Ki67 proliferation index as a tool for chemotherapy decisions during and after neoadjuvant aromatase inhibitor treatment of breast cancer: results from the American College of Surgeons Oncology Group Z1031 Trial (Alliance)","author":"Ellis","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0110","first-page":"83","article-title":"Profile of palbociclib in the treatment of metastatic breast cancer","volume":"8","author":"Ehab","year":"2016","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"354","key":"10.1016\/j.jsbmb.2017.05.005_bib0115","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJMra050776","article-title":"Estrogen carcinogenesis in breast cancer","volume":"2006","author":"Yager","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0120","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0437929100","article-title":"Critical role of oxidative stress in estrogen-induced carcinogenesis","author":"Bhat","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0125","first-page":"40","article-title":"Is estradiol a genotoxic mutagenic carcinogen?","volume":"21","author":"Liehr","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0130","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0960-0760(03)00377-7","article-title":"Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis","volume":"86","author":"Yue","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0135","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/er.2008-0016","article-title":"History of aromatase: saga of an important biological mediator and therapeutic target","volume":"30","author":"Santen","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4048\/jbc.2016.19.2.99","article-title":"Molecular portrait of the normal human breast tissue and its influence on breast carcinogenesis","volume":"19","author":"Margan","year":"2016","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molonc.2010.11.003","article-title":"Deconstructing the molecular portraits of breast cancer","volume":"5","author":"Prat","year":"2011","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/oxfordjournals.jncimonographs.a024247","article-title":"Estrogens as endogenous genotoxic agents\u2013DNA adducts and mutations","volume":"27","author":"Cavalieri","year":"2000","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2003.12.002","article-title":"4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1\u03b1 and vascular endothelial growth factor A through phosphatidylinositol 3-kinase\/Akt\/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells","volume":"196","author":"Gao","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0027-5107(99)00012-3","article-title":"Estrogen, DNA damage and mutations","volume":"424","author":"Roy","year":"1999","journal-title":"Mutat. Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41021-016-0072-6","article-title":"Transgenic rat models for mutagenesis and carcinogenesis","volume":"39","author":"Nohmi","year":"2017","journal-title":"Genes Environ."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/humupd\/7.3.273","article-title":"Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development","volume":"7","author":"Liehr","year":"2001","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0175","first-page":"583","article-title":"The pattern of estradiol and progesterone differs in serum and tissue of benign and malignant ovarian tumors","volume":"21","author":"Lindgren","year":"2002","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0180","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/ijc.28565","article-title":"Unbalanced estrogen metabolism in ovarian cancer","volume":"134","author":"Zahid","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0185","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.18632\/oncotarget.6943","article-title":"Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high-grade serous ovarian cancers","volume":"7","author":"Ciucci","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0190","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1158\/1055-9965.EPI-16-0225","article-title":"Serum estrogens and estrogen metabolites and endometrial cancer risk among postmenopausal women","volume":"25","author":"Brinton","year":"2016","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"9","key":"10.1016\/j.jsbmb.2017.05.005_bib0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1746-1596-9-77","article-title":"Distribution of estrogen and progesterone receptors isoforms in endometrial cancer","volume":"2014","author":"Kreizman-Shefer","year":"2014","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0200","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1200\/JCO.2007.11.3886","article-title":"Selective estrogen-receptor modulators and antihormonal resistance in breast cancer","volume":"25","author":"Jordan","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0205","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1081\/DMR-120033997","article-title":"Genotoxic mechanism of tamoxifen in developing endometrial cancer","volume":"36","author":"Kim","year":"2004","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0210","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/pr.114.009712","article-title":"International union of basic and clinical pharmacology. XCVII. G protein-coupled estrogen receptor and its pharmacologic modulators","volume":"67","author":"Prossnitz","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0215","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.semcancer.2004.06.010","article-title":"Environmental and chemical carcinogenesis","volume":"14","author":"Wogan","year":"2004","journal-title":"Semin. Cancer Biol."},{"issue":"Suppl 1","key":"10.1016\/j.jsbmb.2017.05.005_bib0220","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1093\/toxsci\/kfq365","article-title":"Chemical carcinogenesis","volume":"120","author":"Cohen","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0225","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1101\/pdb.top069906","article-title":"Animal models of chemical carcinogenesis: driving breakthroughs in cancer research for 100 years","volume":"2015","author":"Kemp","year":"2015","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0230","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-physiol-030212-183708","article-title":"Estrogen and cancer","volume":"75","author":"Liang","year":"2013","journal-title":"Ann. Rev. Phys."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0235","first-page":"783","article-title":"Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors. Nat Re","volume":"17","author":"Levin","year":"2016","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0240","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12672-014-0195-9","article-title":"The G protein-coupled estrogen receptor-1, GPER-1, promotes fibrillogenesis via a Shc-dependent pathway resulting in anchorage-independent growth","volume":"5","author":"Magruder","year":"2014","journal-title":"Horm. Cancer."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0245","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1210\/en.2012-1061","article-title":"Minireview: g protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology","volume":"153","author":"Filardo","year":"2012","journal-title":"Endocrinol"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0250","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.mce.2015.07.016","article-title":"The G-protein coupled estrogen receptor, GPER: The inside and inside-out story","volume":"418","author":"Gaudet","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0255","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1006\/geno.1997.4972","article-title":"Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer","volume":"45","author":"Carmeci","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0260","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1006\/bbrc.1997.7734","article-title":"Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress","volume":"240","author":"Takada","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0265","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-5793(97)00278-0","article-title":"A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue","volume":"407","author":"Kvingedal","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0270","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/geno.1998.5095","article-title":"Discovery of three novel G-protein-coupled receptor genes Genomics","volume":"47","author":"O'Dowd","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0275","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.1158\/0008-5472.CAN-07-2293","article-title":"TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling","volume":"67","author":"Woodfield","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0280","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1158\/1078-0432.CCR-06-0860","article-title":"Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression","volume":"12","author":"Filardo","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0285","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1523-1747.2003.12617.x","article-title":"17beta-estradiol inhibits oxidative stress-induced apoptosis in keratinocytes by promoting Bcl-2 expression","volume":"121","author":"Kanda","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0290","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.0022-202X.2004.12645.x","article-title":"17beta-estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression","volume":"123","author":"Kanda","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0295","doi-asserted-by":"crossref","first-page":"e747","DOI":"10.1038\/cddis.2013.275","article-title":"Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells","volume":"4","author":"Chimento","year":"2013","journal-title":"Cell. Death. Dis."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0300","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1096\/fj.08-106492","article-title":"AP-2alpha and AP-2 gamma regulate tumor progression via specific genetic programs","volume":"22","author":"Orso","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0305","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/1940-6207.CAPR-13-0271","article-title":"TFAP2A regulates nasopharyngeal carcinoma growth and survival by targeting HIF-1\u03b1 signaling pathway","volume":"7","author":"Shi","year":"2014","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0310","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10549-009-0631-7","article-title":"GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer","volume":"123","author":"Arias-Pulido","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0315","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.amjsurg.2013.07.014","article-title":"Biology of the estrogen receptor, GPR30, in triple negative breast cancer","volume":"206","author":"Steiman","year":"2013","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0320","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00432-014-1620-8","article-title":"GPER functions as a tumor suppressor in triple-negative breast cancer cells","volume":"140","author":"Weissenborn","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0325","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10549-011-1584-1","article-title":"G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer","volume":"128","author":"Ignatov","year":"2011","journal-title":"Br. Ca Res. Treat"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0330","first-page":"R114","article-title":"GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer","volume":"15","author":"Mo","year":"2013","journal-title":"Br. Ca Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0335","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1210\/mend.14.10.0532","article-title":"Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF","volume":"14","author":"Filardo","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0340","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1757-2215-2-15","article-title":"Aberrant STYK1 expression in ovarian cancer tissues and cell lines","volume":"2","author":"Jackson","year":"2009","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-013-1579-9","article-title":"The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells","volume":"378","author":"Yan","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0350","doi-asserted-by":"crossref","first-page":"472720","DOI":"10.1155\/2013\/472720","article-title":"G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth","volume":"2013","author":"Petrie","year":"2013","journal-title":"Obstet. Gynecol. Int."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0355","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer recurrence and 15-year survival: an overview of randomized trials","volume":"365","author":"Early Breast Cancer Trialist\u2019 Collaborative Group","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0360","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1200\/JCO.2015.61.2259","article-title":"Twelve-month estrogen levels in premenopausal women with hormone receptor-positive breast cancer receiving adjuvant triptorelin plus exemestane or tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy","volume":"34","author":"Bellet","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0365","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/gyno.2000.5865","article-title":"A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study","volume":"78","author":"Rose","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0370","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/ijgc-00009577-200807000-00002","article-title":"Aromatase inhibitors in ovarian cancer: is there a role?","volume":"18","author":"Li","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0375","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ygyno.2010.03.014","article-title":"Hormone prevention strategies for breast, endometrial and ovarian cancers","volume":"118","author":"Rice","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0380","doi-asserted-by":"crossref","first-page":"479541","DOI":"10.1155\/2013\/479541","article-title":"The estrogen receptor joins other cancer biomarkers as a predictor of outcome","volume":"2013","author":"Leslie","year":"2013","journal-title":"Obstet. Gynecol. Int."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0385","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ogc.2012.04.001","article-title":"Endometrial cancer","volume":"39","author":"Leslie","year":"2012","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0390","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12957-015-0619-1","article-title":"Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0395","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1210\/en.2009-0070","article-title":"Minireview: obesity and breast cancer: the estrogen connection","volume":"150","author":"Cleary","year":"2009","journal-title":"Endocrinol"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0400","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/epirev\/mxt010","article-title":"Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status","volume":"36","author":"Munsell","year":"2014","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0405","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10549-015-3353-z","article-title":"Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium","volume":"150","author":"Bandera","year":"2015","journal-title":"Br. Canc Res. Treat"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0410","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060989","article-title":"The obesity- breast cancer conundrum: an analysis of the issues","volume":"17","author":"Matthews","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0415","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/CIRCRESAHA.108.190892","article-title":"Regulatory role of G Protein-Coupled Estrogen Receptor for vascular function and obesity","volume":"104","author":"Haas","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0420","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/en.2008-0623","article-title":"Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice","volume":"150","author":"Martensson","year":"2009","journal-title":"Endocrinol"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0425","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1748-1716.2010.02237.x","article-title":"Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptor","volume":"203","author":"Meyer","year":"2011","journal-title":"Acta Physiol. (Oxf)."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0430","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1210\/en.2013-1357","article-title":"GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state","volume":"154","author":"Sharma","year":"2013","journal-title":"Endocrinol"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0435","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.12416","article-title":"Obesity and cancer pathogenesis","volume":"1311","author":"Berger","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0440","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","article-title":"Sources of estrogen and their importance","volume":"86","author":"Simpson","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0445","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jsbmb.2014.06.001","article-title":"All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause","volume":"145","author":"Labrie","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0450","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1871522211108040243","article-title":"GPER and ER: estrogen receptors with distinct biological roles in breast cancer","volume":"11","author":"Filardo","year":"2011","journal-title":"Immuno. Endocr. Metab. Agents Med. Chem."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0455","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/apm.12241","article-title":"Immunohistochemical expression of GPR30 in breast carcinoma of Egyptian patients: an association with immunohistochemical subtypes","volume":"122","author":"Aiad","year":"2014","journal-title":"APMIS"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0460","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0960-0760(01)00190-X","article-title":"Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer","volume":"80","author":"Filardo","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0465","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ygyno.2009.05.015","article-title":"GPR30 predicts poor survival for ovarian cancer","volume":"114","author":"Smith","year":"2009","journal-title":"Gyn. Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0470","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/IGC.0b013e318247323d","article-title":"Transmembrane estrogen receptor GPR30 is more frequently expressed in malignant than benign ovarian endometriotic cysts and correlates with MMP-9 expression","volume":"22","author":"Long","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0475","first-page":"381","article-title":"GPR30: a novel indicator of poor survival for endometrial carcinoma","volume":"196","author":"Smith","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0480","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1757-2215-5-9","article-title":"The G protein-coupled estrogen receptor 1 (GPER\/GPR30) does not predict survival in patients with ovarian cancer","volume":"5","author":"Kolkova","year":"2012","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0485","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1757-2215-6-51","article-title":"GPER-1 acts as a tumor suppressor in ovarian cancer","volume":"6","author":"Ignatov","year":"2013","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0490","doi-asserted-by":"crossref","first-page":"e71791","DOI":"10.1371\/journal.pone.0071791","article-title":"The G-protein coupled estrogen receptor (GPER\/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients","volume":"8","author":"Heublein","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0495","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/bjc.2012.91","article-title":"Loss of GPER identifies new targets for therapy among a subgroup of ER\u00d8-positive endometrial cancer patients with poor outcome","volume":"106","author":"Krakstad","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0500","doi-asserted-by":"crossref","first-page":"273e285","DOI":"10.1007\/s10549-014-3017-4","article-title":"Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth","volume":"146","author":"Catalano","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0505","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cbf.3154","article-title":"Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3","volume":"33","author":"Yan","year":"2015","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0510","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/1541-7786.MCR-14-0128-T","article-title":"G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis","volume":"12","author":"Marjon","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0515","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.steroids.2006.10.009","article-title":"Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer","volume":"72","author":"Jordan","year":"2007","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0520","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.repbio.2013.12.002","article-title":"Estrogen hormone physiology: reproductive findings from estrogen receptor mutant mice","volume":"14","author":"Hamilton","year":"2014","journal-title":"Reprod. Biol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0525","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1158\/0008-5472.CAN-06-2909","article-title":"G-protein coupled receptor 30 (GPR30) mediates gene expression, changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells","volume":"67","author":"Albanito","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0530","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jsbmb.2011.07.002","article-title":"Identification of a GPER\/GPR30 antagonist with improved estrogen receptor counterselectivity","volume":"127","author":"Dennis","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0535","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nchembio775","article-title":"Virtual and biomolecular screening converge on a selective agonist for GPR30","volume":"2","author":"Bologa","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0540","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nchembio.168","article-title":"In vivo effects of a GPR30 antagonist","volume":"5","author":"Dennis","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0545","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1208\/s12248-015-9844-3","article-title":"Macromolecular modelling and docking simulations for the discovery of selective GPER ligands","volume":"18","author":"Rosano","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0550","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4161\/cc.5.14.2983","article-title":"Deciphering the mammary epithelial cell hierarchy","volume":"5","author":"Stingl","year":"2006","journal-title":"ABBV Cell Cycle"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0555","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrm4056","article-title":"Ovary and fimbrial stem cells: biology, niche and cancer origins","volume":"16","author":"Ng","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0560","first-page":"137","article-title":"Endometrial stem\/progenitor cells: the first 10 years","volume":"22","author":"Gargett","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0565","doi-asserted-by":"crossref","first-page":"ra98","DOI":"10.1126\/scisignal.2004427","article-title":"Regulation of epithelial morphogenesis by the G protein-coupled receptor mist and its ligand fog","volume":"6","author":"Manning","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0570","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-12-394587-7.00005-1","article-title":"GPCRs in stem cell function","volume":"115","author":"Doze","year":"2013","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0575","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.drup.2008.07.001","article-title":"Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers","volume":"11","author":"Sabbah","year":"2008","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0580","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cbin.10243","article-title":"A novel estrogen receptor GPER mediates proliferation induced by 17\u03b2-estradiol and selective GPER agonist G-1 in estrogen receptor \u03b1 (ER\u03b1)-negative ovarian cancer cells","volume":"38","author":"Liu","year":"2014","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0585","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1021\/cr000101f","article-title":"Growth factor-dependent signaling and cell cycle progression","volume":"101","author":"Jones","year":"2001","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0590","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1210\/me.2008-0262","article-title":"Coordinate regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by the G protein-coupled receptor, GPR30","volume":"23","author":"Quinn","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0595","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1128\/MCB.15.3.1182","article-title":"Single-chain antibody mediated intracellular retention of ErbB2 impairs neu differentiation factor and epidermal growth factor signaling","volume":"15","author":"Graus-Porta","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0600","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-2187-2-2","article-title":"Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression","volume":"2","author":"New","year":"2007","journal-title":"J. Mol. Signal."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0605","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/mend.16.1.0758","article-title":"Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis","volume":"16","author":"Filardo","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0610","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.1106943","article-title":"A transmembrane intracellular estrogen receptor mediates rapid cell signaling","volume":"307","author":"Revankar","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0615","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/IGC.0b013e31827912b8","article-title":"The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3 K\/Akt pathway in endometrial cancer cells","volume":"23","author":"Ge","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0620","doi-asserted-by":"crossref","first-page":"26453","DOI":"10.1074\/jbc.M101289200","article-title":"Orphan G protein-coupled receptor, GPR41, induces apoptosis via a p53\/Bax pathway during ischemic hypoxia and reoxygenation","volume":"276","author":"Kimura","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0625","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40661-016-0035-4","article-title":"New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care","volume":"3","author":"Talhouk","year":"2016","journal-title":"Gynecol. Oncol. Res. Pract."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0630","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/emboj\/17.8.2139","article-title":"Perturbation of beta1-integrin function alters the development of murine mammary gland","volume":"17","author":"Faraldo","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0635","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.25.022106.141618","article-title":"Structural basis of integrin regulation and signaling","volume":"25","author":"Luo","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0640","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00432-011-1133-7","article-title":"Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2","volume":"138","author":"He","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0645","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/IGC.0b013e31819bcb75","article-title":"Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells","volume":"19","author":"Henic","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0650","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1128\/MCB.00772-15","article-title":"Myocardin-Related transcription factor a and yes-Associated protein exert dual control in G protein-Coupled receptor- and rhoA-Mediated transcriptional regulation and cell proliferation","volume":"36","author":"Yu","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0655","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI79573","article-title":"Estrogen regulates Hippo signaling via GPER in breast cancer","volume":"125","author":"Zhou","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0660","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/rep.0.1210181","article-title":"Human endometrial angiogenesis","volume":"121","author":"Gargett","year":"2001","journal-title":"Reproduction"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0665","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"OncomiR or tumor suppressor? the duplicity of MicroRNAs in cancer","volume":"76","author":"Svoronos","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0670","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1078-0432.CCR-12-2241","article-title":"Does microenvironment contribute to the etiology of estrogen receptor-negative breast cancer?","volume":"19","author":"Barcellos-Hoff","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0675","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/aps.2011.183","article-title":"GPCRs and cancer","volume":"33","author":"Lappano","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0680","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17081320","article-title":"G protein-Coupled receptors in cancer","volume":"17","author":"Bar-Shavit","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0685","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.canlet.2016.03.031","article-title":"G protein-coupled receptors as promising cancer targets","volume":"376","author":"Liu","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0690","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.onc.1207278","article-title":"Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion","volume":"23","author":"Sch\u00e4fer","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0695","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.15252\/embj.201490147","article-title":"The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer","volume":"34","author":"Antonio","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0700","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/IGC.0b013e3181a1b5dc","article-title":"High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy","volume":"19","author":"Hirst","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0705","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1073\/pnas.1201029109","article-title":"Nonovarian origins of ovarian cancer","volume":"109","author":"Hillier","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0710","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13058-015-0579-y","volume":"17","author":"Yuan","year":"2015","journal-title":"Br. Canc Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0715","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/CJI.0b013e31828d8e3b","article-title":"The G protein-coupled estrogen receptor (GPER) agonist G-1 expands the regulatory T-cell population under TH17-polarizing conditions","volume":"36","author":"Brunsing","year":"2013","journal-title":"J. Immunother."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0720","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1038\/srep07564","article-title":"G protein-coupled receptor protects from atherosclerosis","volume":"4","author":"Meyer","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0725","doi-asserted-by":"crossref","first-page":"40534064","DOI":"10.1158\/0008-5472.CAN-13-3590","article-title":"GPER mediates activation of HIFa\/VEGF signaling by estrogens","volume":"74","author":"De Francesco","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0730","first-page":"27","article-title":"GPER is involved in the functional liaison between breast tumor cells and cancer-associated fibroblasts (CAFs)","author":"Lappano","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0735","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2016.11.003","article-title":"Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-(B\/IL-6 signals","volume":"386","author":"Liang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0740","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/11589180-000000000-00000","article-title":"Estrogen and skin: therapeutic options","volume":"12","author":"Shu","year":"2011","journal-title":"Am. J. Clin. Dermatol."},{"issue":"Suppl 2","key":"10.1016\/j.jsbmb.2017.05.005_bib0745","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/09513590.2012.705392","article-title":"Postmenopausal skin and estrogen","volume":"28","author":"Archer","year":"2012","journal-title":"Gynecol. Endocrinol."},{"issue":"2","key":"10.1016\/j.jsbmb.2017.05.005_bib0750","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/bcr3410","article-title":"HIF-1\u03b1 stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma","volume":"15","author":"Samarajeewa","year":"2013","journal-title":"Br Can Res."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0755","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ijc.28679","article-title":"Activation of a positive feedback loop involving IL-6 and aromatase promotes intratumoral 17beta-estradiol biosynthesis in endometrial carcinoma microenvironment","volume":"135","author":"Che","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0760","first-page":"377","article-title":"Role of estrogen in angiogenesis in cardiovascular diseases","volume":"10","author":"Barnabas","year":"2013","journal-title":"J. Geriatr. Cardiol."},{"key":"10.1016\/j.jsbmb.2017.05.005_bib0765","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/bbrc.1996.1654","article-title":"Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues","volume":"228","author":"Owman","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.jsbmb.2017.05.005_bib0770","doi-asserted-by":"crossref","first-page":"e72999","DOI":"10.1371\/journal.pone.0072999","article-title":"Estradiol and tamoxifen induce cell migration through GPR 30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor \u03b1 (ER\u03b1)","volume":"8","author":"Tsai","year":"2013","journal-title":"PLoS One"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076017301292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076017301292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:57:39Z","timestamp":1760745459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076017301292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":154,"alternative-id":["S0960076017301292"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2017.05.005","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: Dysregulated glandular homeostasis, survival and metastasis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}